Aldeyra Therapeutics, Inc.
Cash Flow History
| Fiscal Year | Operating Cash Flow | Free Cash Flow | CapEx | Share-Based Compensation |
|---|---|---|---|---|
| FY2020 | $-37.5M | $-37.5M | — | $7.1M |
| FY2021 | $-42.6M | $-42.6M | $7.8K | $7.1M |
| FY2022 | $-56.6M | $-56.7M | $16.3K | $8.3M |
| FY2023 | $-30.3M | $-30.3M | $0 | $5.8M |
| FY2024 | $-43.2M | $-43.2M | — | $8.0M |